Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Acne Vulgaris D000152 35 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adenoma D000236 40 associated lipids
Anaphylaxis D000707 35 associated lipids
Anemia D000740 21 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Fabry Disease D000795 4 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Asthma D001249 52 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Edema D004487 152 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Eye Abnormalities D005124 7 associated lipids
Fibrosis D005355 23 associated lipids
Glioblastoma D005909 27 associated lipids
Glioma D005910 112 associated lipids
Heart Failure D006333 36 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hyperalgesia D006930 42 associated lipids
Hypersensitivity D006967 22 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hypertension D006973 115 associated lipids
Inflammation D007249 119 associated lipids
Influenza, Human D007251 11 associated lipids
Insulin Resistance D007333 99 associated lipids
Insulinoma D007340 28 associated lipids
Leukemia D007938 74 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Lung Neoplasms D008175 171 associated lipids
Melanoma D008545 69 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Cardiomyopathies D009202 10 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Nerve Degeneration D009410 53 associated lipids
Neuralgia D009437 28 associated lipids
Neuroblastoma D009447 66 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Ovarian Diseases D010049 5 associated lipids
Pain D010146 64 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Proteinuria D011507 30 associated lipids
Psoriasis D011565 47 associated lipids
Pulmonary Edema D011654 23 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Retinal Detachment D012163 10 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Sarcoma 180 D012510 21 associated lipids
Sensation Disorders D012678 2 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Thrombocytopenia D013921 15 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Tuberculosis D014376 20 associated lipids
Vascular Diseases D014652 16 associated lipids
Reperfusion Injury D015427 65 associated lipids
Weight Gain D015430 101 associated lipids
Teratocarcinoma D018243 7 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Endotoxemia D019446 27 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Ileus D045823 3 associated lipids
Atherosclerosis D050197 85 associated lipids
Niemann-Pick Disease, Type C D052556 1 associated lipids
Lung Injury D055370 14 associated lipids
Acute Lung Injury D055371 33 associated lipids
Farber Lipogranulomatosis D055577 1 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Abuhusain HJ et al. A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis. 2013 J. Biol. Chem. pmid:24265321
Bolli MH et al. Novel S1P1 receptor agonists--part 1: From pyrazoles to thiophenes. 2013 J. Med. Chem. pmid:24266709
Das A et al. The promotion of mandibular defect healing by the targeting of S1P receptors and the recruitment of alternatively activated macrophages. 2013 Biomaterials pmid:24064148
Xiang SY et al. Lysophospholipid receptor activation of RhoA and lipid signaling pathways. 2013 Biochim. Biophys. Acta pmid:22986288
Gaveglio VL et al. Phosphatidic acid metabolism in rat liver cell nuclei. 2013 FEBS Lett. pmid:23439070
Harijith A et al. Sphingosine kinase 1 deficiency confers protection against hyperoxia-induced bronchopulmonary dysplasia in a murine model: role of S1P signaling and Nox proteins. 2013 Am. J. Pathol. pmid:23933064
Cortez-Retamozo V et al. Angiotensin II drives the production of tumor-promoting macrophages. 2013 Immunity pmid:23333075
Ono Y et al. Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration. 2013 Lipids Health Dis pmid:23418753
Bot M et al. Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice. 2013 PLoS ONE pmid:23700419
García-Bernal D et al. Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function. 2013 J. Pathol. pmid:22711564
Takuwa Y et al. Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases. 2013 Biochim. Biophys. Acta pmid:22735357
Olivera A et al. Shaping the landscape: metabolic regulation of S1P gradients. 2013 Biochim. Biophys. Acta pmid:22735358
Karliner JS Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress. 2013 Biochim. Biophys. Acta pmid:22735359
Walls SM et al. Identification of sphingolipid metabolites that induce obesity via misregulation of appetite, caloric intake and fat storage in Drosophila. 2013 PLoS Genet. pmid:24339790
Brewer JW Phospholipids: "greasing the wheels" of humoral immunity. 2013 Biochim. Biophys. Acta pmid:23051607
Mierzejewska K et al. Sphingosine-1-phosphate-mediated mobilization of hematopoietic stem/progenitor cells during intravascular hemolysis requires attenuation of SDF-1-CXCR4 retention signaling in bone marrow. 2013 Biomed Res Int pmid:24490172
Polzin A et al. Aspirin inhibits release of platelet-derived sphingosine-1-phosphate in acute myocardial infarction. 2013 Int. J. Cardiol. pmid:24169533
Kunkel GT et al. Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. 2013 Nat Rev Drug Discov pmid:23954895
Gorshkova IA et al. Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest. 2013 Life Sci. pmid:23892195
Loetscher E et al. Assay to measure the secretion of sphingosine-1-phosphate from cells induced by S1P lyase inhibitors. 2013 Biochem. Biophys. Res. Commun. pmid:23499842
Moriue T et al. Sphingosine 1-phosphate attenuates peroxide-induced apoptosis in HaCaT cells cultured in vitro. 2013 Clin. Exp. Dermatol. pmid:23837937
Adada M et al. Sphingosine-1-phosphate receptor 2. 2013 FEBS J. pmid:23879641
Gao X et al. Aberrant sphingolipid metabolism in the human fallopian tube with ectopic pregnancy. 2013 Lipids pmid:23881382
Karimian G et al. Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis. 2013 Biochim. Biophys. Acta pmid:23816565
Liu Y et al. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors. 2013 J. Pathol. pmid:23839903
Goyal P et al. Cytokine IL-6 secretion by trophoblasts regulated via sphingosine-1-phosphate receptor 2 involving Rho/Rho-kinase and Rac1 signaling pathways. 2013 Mol. Hum. Reprod. pmid:23538947
Billich A et al. Cellular assay for the characterization of sphingosine-1-phosphate lyase inhibitors. 2013 Anal. Biochem. pmid:23246729
Karapetyan AV et al. Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction. 2013 Stem Cells Dev. pmid:23282236
Kleinjan A et al. Topical treatment targeting sphingosine-1-phosphate and sphingosine lyase abrogates experimental allergic rhinitis in a murine model. 2013 Allergy pmid:23253209
Kager LM et al. Endogenous protein C has a protective role during Gram-negative pneumosepsis (melioidosis). 2013 J. Thromb. Haemost. pmid:23216621
Liang J et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. 2013 Cancer Cell pmid:23273921
Jiang LI et al. Regions on adenylyl cyclase VII required for selective regulation by the G13 pathway. 2013 Mol. Pharmacol. pmid:23229509
Park K et al. A novel role of a lipid species, sphingosine-1-phosphate, in epithelial innate immunity. 2013 Mol. Cell. Biol. pmid:23230267
Camprubí-Robles M et al. Sphingosine-1-phosphate-induced nociceptor excitation and ongoing pain behavior in mice and humans is largely mediated by S1P3 receptor. 2013 J. Neurosci. pmid:23392686
Matsuzaki E et al. Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines. 2013 Bone pmid:23612487
Dusaban SS et al. Phospholipase C epsilon links G protein-coupled receptor activation to inflammatory astrocytic responses. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23401561
Kalhori V et al. Sphingosine-1-Phosphate as a Regulator of Hypoxia-Induced Factor-1α in Thyroid Follicular Carcinoma Cells. 2013 PLoS ONE pmid:23824493
Cartwright TA et al. Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers. 2013 J. Cereb. Blood Flow Metab. pmid:23168528
Guo H et al. An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway. 2013 J. Neurosci. pmid:23554499
Véret J et al. Role of palmitate-induced sphingoid base-1-phosphate biosynthesis in INS-1 β-cell survival. 2013 Biochim. Biophys. Acta pmid:23085009
Lotinun S et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. 2013 J. Clin. Invest. pmid:23321671
Nguyen DH et al. Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23569284
Alberg AJ et al. Plasma sphingolipids and lung cancer: a population-based, nested case-control study. 2013 Cancer Epidemiol. Biomarkers Prev. pmid:23749868
Willis MA and Cohen JA Fingolimod therapy for multiple sclerosis. 2013 Semin Neurol pmid:23709211
Tatematsu S et al. Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium. 2013 Arterioscler. Thromb. Vasc. Biol. pmid:23723371
Guo L et al. Sphingosine-1-phosphate inhibits ceramide-induced apoptosis during murine preimplantation embryonic development. 2013 Theriogenology pmid:23731666
Zhang L et al. Sphingosine kinase 2 (Sphk2) regulates platelet biogenesis by providing intracellular sphingosine 1-phosphate (S1P). 2013 Blood pmid:23775711
Koch A et al. Sphingosine 1-phosphate in renal diseases. 2013 Cell. Physiol. Biochem. pmid:23736205
Huang LS et al. Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis. 2013 FASEB J. pmid:23315259
Fukuhara S and Mochizuki N [Lymphocytes mobilization into blood regulated by Spns2, a sphingosine 1-phosphate transporter, expressed on endothelial cells]. 2013 Seikagaku pmid:23717873